The Library Media — Business & Markets · Markets Desk
Anthropic’s IPO: The Market Is Bidding Above the Paper
By Clara Ledger
Follow The Library Media
The price range is $70 to $78 a share. The market, according to reports from the people arranging and trading around the deal, may already be asking for more.
The Financial Times reported late Tuesday, citing five people familiar with the matter, that Anthropic’s bankers are weighing an IPO price above the range disclosed in Amendment No. 2. At $1.5 trillion or more in valuation, the offering would raise more than $100 billion, the FT reported. That is not a revised offer price. It is reported pricing discussion, and there is an important difference between a banker weighing a number and a company filing one.
The arithmetic shows what that discussion implies. Using the filing’s approximately 17.98 billion fully diluted shares, a $1.5 trillion valuation works out to roughly $83 a share. That is about 7% above the $78 top of the filed range. This is a calculation from the disclosed share count, not a new price in the prospectus.
Demand appears to be giving the bankers room to consider the change. CNBC reported that the book was already covered at the filed range on an allocable basis on day one, with institutional demand running ahead of SpaceX at the same stage. A covered book is evidence of orders at the terms being marketed; it is not proof that every order will remain, that every investor will receive an allocation, or that the final price has been settled.
Bloomberg reported that side trading through JonesTrading was already running 3% to 5% above the IPO price. Bloomberg also reported that a further $1.25 billion special-purpose vehicle had been offered at a $1.5 trillion valuation. Those are indications of activity around the deal, not the IPO’s official price. Bloomberg reported, too, that Anthropic has warned it will not recognise certain pre-IPO secondary offers. A price quoted in a secondary transaction does not become the company’s public offering price by repetition.
The reversal is striking. Last week, on November 6, the discussion reported at the time was materially lower: buyer discussions pointed to a $1.2 trillion to $1.3 trillion valuation, while around $1 trillion was seen as workable. Now the FT reports that bankers are weighing a level of $1.5 trillion or more. The change is not a new revenue figure in this pack. It is a change in reported appetite for the same business and the same proposed listing.
The underlying prospectus arithmetic has not disappeared. The filed range remains $70 to $78; the base offering is 825 million shares, with a 123.75 million-share greenshoe. The concurrent approximately $26 billion non-voting Class N placement is being taken up by Anthropic’s own suppliers. Run-rate revenue was approximately $81 billion as of October 31. The prospectus also includes risk factors addressing the moral status of AI systems and the possibility of catastrophic harm that may be uninsurable.
That last disclosure makes the market’s reported behaviour notable, not contradictory. Investors can price growth, scarcity and demand while a prospectus lays out risks that are difficult to quantify or insure. A book covered above the minimum required to sell the shares does not mean those risks have been resolved. Nor does a higher valuation mean the market has found a dollar figure for them. It means reported demand is strong enough that the bankers are considering whether the filed range captures what buyers may pay.
There is still a document between the talk and the transaction. Amendment No. 2, filed November 10, remains the latest filing on EDGAR. No new filing has yet changed the $70 to $78 range. Any revised price range or offering terms must appear in a new filing before an above-range price is real on paper. Pricing is expected next week, with trading to follow on Nasdaq under ticker ANT.
For now, the market is bidding around the prospectus, not rewriting it. The measure is the same as yesterday: distinguish reported interest from filed terms, a secondary indication from an IPO price, and a valuation calculation from a number the company has formally put on the page.
— Clara Ledger, Markets Desk
From The Library — the estate of our family.